Recent News

• 05.21.2025 - Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
• 05.12.2025 - Cellectis Reports Financial Results for the First Quarter 2025
• 05.06.2025 - Cellectis to Report First Quarter Financial Results on May 12, 2025
• 04.28.2025 - Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
• 03.13.2025 - Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Recent Filings

• 05.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.12.2025 - EX-99.1 EX-99.1
• 05.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.12.2025 - EX-99.1 EX-99.1
• 05.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.06.2025 - EX-99.1 EX-99.1
• 04.28.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.28.2025 - EX-99.1 EX-99.1
• 03.31.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.14.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]